Celldex Therapeutics shares owned by Virtus ETF Advisers
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Virtus ETF Advisers
from 13F filings
Historical chart of Virtus ETF Advisers investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Virtus ETF Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Virtus ETF Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $102k | 2.6k | 39.66 |
| 2023-09-30 | $72k | 2.6k | 27.52 |
| 2023-06-30 | $98k | 2.9k | 33.93 |
| 2023-03-31 | $90k | 2.5k | 35.98 |
| 2022-12-31 | $155k | 3.5k | 44.57 |
| 2022-09-30 | $136k | 4.8k | 28.06 |
| 2022-06-30 | $130k | 4.8k | 26.99 |
| 2022-03-31 | $141k | 4.1k | 34.13 |
| 2021-12-31 | $169k | 4.4k | 38.57 |
| 2021-09-30 | $425k | 7.9k | 54.04 |
| 2021-06-30 | $278k | 8.3k | 33.49 |
| 2021-03-31 | $339k | 17k | 20.59 |
| 2020-12-31 | $283k | 16k | 17.50 |